PHRRF vs REGN: Which Stock is Better?
Side-by-side comparison of Pharmather Holdings Ltd and Regeneron Pharmaceuticals Inc in 2026
PHRRF
Pharmather Holdings Ltd
—
REGN
Regeneron Pharmaceuticals Inc
$676.69
Key Metrics Comparison
| Metric | PHRRF | REGN | Winner |
|---|---|---|---|
| Market Cap | $29.21M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHRRF
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHRRF or REGN a better investment?
Comparing PHRRF and REGN: Pharmather Holdings Ltd has a market cap of $29.21M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHRRF and REGN?
PHRRF (Pharmather Holdings Ltd) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHRRF or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHRRF or REGN?
Both PHRRF and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHRRF or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHRRF or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $29.21M for PHRRF.
Should I buy PHRRF or REGN in 2026?
Both PHRRF and REGN have investment merit. PHRRF trades at $N/A while REGN trades at $676.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHRRF and REGN stock?
Key differences: Market Cap ($29.21M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHRRF or REGN in 2026?
The choice between PHRRF and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHRRF and REGN?
PHRRF (Pharmather Holdings Ltd) has a market cap of $29.21M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.